Literature DB >> 25869939

The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication.

Alessandro F Fois1, Bruce J Brew.   

Abstract

The ability of HIV-1 to establish latent infection is a key obstacle to its eradication despite the existence of effective antiretroviral drugs. The brain has been postulated as a reservoir for latent infection, but its role in HIV persistence remains unclear. In this review, we discuss the evidence surrounding the role of the central nervous system (CNS) as a viral reservoir and the potential challenges this might present in eradicating HIV. The strategies for eradication of HIV and their application to latent CNS infection are explored. Finally, we outline new developments in drug delivery and new therapeutic modalities designed to target HIV infection in the CNS.

Entities:  

Mesh:

Year:  2015        PMID: 25869939     DOI: 10.1007/s11904-015-0257-9

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  42 in total

1.  Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry.

Authors:  K Takahashi; S L Wesselingh; D E Griffin; J C McArthur; R T Johnson; J D Glass
Journal:  Ann Neurol       Date:  1996-06       Impact factor: 10.422

2.  HIV rebounds from latently infected cells, rather than from continuing low-level replication.

Authors:  Beda Joos; Marek Fischer; Herbert Kuster; Satish K Pillai; Joseph K Wong; Jürg Böni; Bernard Hirschel; Rainer Weber; Alexandra Trkola; Huldrych F Günthard
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

3.  In situ amplification and detection of HIV-1 DNA in fixed pediatric AIDS brain tissue.

Authors:  L R Sharer; Y Saito; A Da Cunha; P C Ung; H A Gelbard; L G Epstein; B M Blumberg
Journal:  Hum Pathol       Date:  1996-06       Impact factor: 3.466

4.  RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma.

Authors:  David L DiGiusto; Amrita Krishnan; Lijing Li; Haitang Li; Shirley Li; Anitha Rao; Shu Mi; Priscilla Yam; Sherri Stinson; Michael Kalos; Joseph Alvarnas; Simon F Lacey; Jiing-Kuan Yee; Mingjie Li; Larry Couture; David Hsu; Stephen J Forman; John J Rossi; John A Zaia
Journal:  Sci Transl Med       Date:  2010-06-16       Impact factor: 17.956

Review 5.  A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system.

Authors:  Janice E Clements; Lucio Gama; David R Graham; Joseph L Mankowski; M C Zink
Journal:  Curr Opin HIV AIDS       Date:  2011-01       Impact factor: 4.283

6.  Effects of atorvastatin and pravastatin on immune activation and T-cell function in antiretroviral therapy-suppressed HIV-1-infected patients.

Authors:  Edgar Turner Overton; Sarah Sterrett; Andrew O Westfall; Shannon M Kahan; Greer Burkholder; Allan J Zajac; Paul A Goepfert; Anju Bansal
Journal:  AIDS       Date:  2014-11-13       Impact factor: 4.177

Review 7.  Pathogenesis of HIV in the central nervous system.

Authors:  Victor Valcour; Pasiri Sithinamsuwan; Scott Letendre; Beau Ances
Journal:  Curr HIV/AIDS Rep       Date:  2011-03       Impact factor: 5.071

8.  Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.

Authors:  Kai Deng; Mihaela Pertea; Anthony Rongvaux; Leyao Wang; Christine M Durand; Gabriel Ghiaur; Jun Lai; Holly L McHugh; Haiping Hao; Hao Zhang; Joseph B Margolick; Cagan Gurer; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Steven G Deeks; Till Strowig; Priti Kumar; Janet D Siliciano; Steven L Salzberg; Richard A Flavell; Liang Shan; Robert F Siliciano
Journal:  Nature       Date:  2015-01-07       Impact factor: 49.962

9.  The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes.

Authors:  Lachlan R Gray; Gilda Tachedjian; Anne M Ellett; Michael J Roche; Wan-Jung Cheng; Gilles J Guillemin; Bruce J Brew; Stuart G Turville; Steve L Wesselingh; Paul R Gorry; Melissa J Churchill
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

10.  HIV-1 entry and trans-infection of astrocytes involves CD81 vesicles.

Authors:  Lachlan R Gray; Stuart G Turville; Tina L Hitchen; Wan-Jung Cheng; Anne M Ellett; Hamid Salimi; Michael J Roche; Steve L Wesselingh; Paul R Gorry; Melissa J Churchill
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more
  32 in total

1.  Development and characterization of a long-acting nanoformulated abacavir prodrug.

Authors:  Dhirender Singh; JoEllyn McMillan; James Hilaire; Nagsen Gautam; Diana Palandri; Yazen Alnouti; Howard E Gendelman; Benson Edagwa
Journal:  Nanomedicine (Lond)       Date:  2016-07-26       Impact factor: 5.307

2.  Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders.

Authors:  Michael T Nedelcovych; Boe-Hyun Kim; Xiaolei Zhu; Lyndah E Lovell; Arena A Manning; Jennifer Kelschenbach; Eran Hadas; Wei Chao; Eva Prchalová; Ranjeet P Dash; Ying Wu; Jesse Alt; Ajit G Thomas; Rana Rais; Atsushi Kamiya; David J Volsky; Barbara S Slusher
Journal:  J Neuroimmune Pharmacol       Date:  2019-06-17       Impact factor: 4.147

Review 3.  Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System.

Authors:  Nithya Srinivas; Kaitlyn Maffuid; Angela D M Kashuba
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

Review 4.  HIV-associated neurodegeneration: exploitation of the neuronal cytoskeleton.

Authors:  Erin D Wenzel; Valeria Avdoshina; Italo Mocchetti
Journal:  J Neurovirol       Date:  2019-03-08       Impact factor: 2.643

Review 5.  Gene Editing for Treatment of Neurological Infections.

Authors:  Martyn K White; Rafal Kaminski; Hassen Wollebo; Wenhui Hu; Thomas Malcolm; Kamel Khalili
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

6.  FDC:TFH Interactions within Cervical Lymph Nodes of SIV-Infected Rhesus Macaques.

Authors:  Rajnish S Dave; Ravi K Sharma; Roshell R Muir; Elias Haddad; Sanjeev Gumber; Francois Villinger; Artinder P Nehra; Zafar K Khan; Brian Wigdahl; Aftab A Ansari; Siddappa N Byrareddy; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2017-12-29       Impact factor: 4.147

Review 7.  Neurologic Complications in Treated HIV-1 Infection.

Authors:  Nisha S Bhatia; Felicia C Chow
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

Review 8.  HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Authors:  Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

Review 9.  Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System.

Authors:  Luc Bertrand; Madhavan Nair; Michal Toborek
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 10.  The role of human dopamine transporter in NeuroAIDS.

Authors:  Jun Zhu; Subramaniam Ananthan; Chang-Guo Zhan
Journal:  Pharmacol Ther       Date:  2017-10-05       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.